PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+37.7%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$2.61B
AUM Growth
+$2.61B
(+35%)
Cap. Flow
+$227M
Cap. Flow
% of AUM
8.69%
Top 10 Holdings %
Top 10 Hldgs %
54.25%
Holding
163
New
39
Increased
29
Reduced
17
Closed
28
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$74.4M |
| 2 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$38.7M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$33.8M |
| 4 |
Puma Biotechnology
PBYI
|
$22.8M |
| 5 |
CBAY
Cymabay Therapeutics
CBAY
|
$18.9M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$36.7M |
| 2 |
RDUS
Radius Health, Inc.
RDUS
|
$29.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$21.1M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$13.3M |
| 5 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$13.3M |
Sector Composition
| 1 | Healthcare | 95.78% |
| 2 | Industrials | 0.33% |
| 3 | Consumer Discretionary | 0.07% |
| 4 | Technology | 0.01% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
Jazz Pharmaceuticals
JAZZ
$7.99B
| – | – |
-85,572
| Closed | -$13.3M |
|
152
Ionis Pharmaceuticals
IONS
$9.64B
| – | – |
0
| – | – |
|
153
Icon
ICLR
$14B
| – | – |
-5,187
| Closed | -$507K |
|
154
EyePoint Pharmaceuticals
EYPT
$827M
| – | – |
-1,149,556
| Closed | -$1.97M |
|
155
Edwards Lifesciences
EW
$47.7B
| – | – |
-6,088
| Closed | -$719K |
|
156
Cidara Therapeutics
CDTX
$1.61B
| – | – |
-62,110
| Closed | -$465K |
|
|
BLUE
157
DELISTED
bluebird bio
BLUE
| – | – |
-20,000
| Closed | -$2.1M |
|
158
Arrowhead Research
ARWR
$3.84B
| – | – |
-847,458
| Closed | -$1.37M |
|
159
ANI Pharmaceuticals
ANIP
$2.06B
| – | – |
-125,399
| Closed | -$5.87M |
|